{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:51:26Z","timestamp":1759683086040,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.psyneuen.2004.02.007","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T14:22:43Z","timestamp":1090419763000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Twenty-four hour growth hormone secretion in patients with panic disorder"],"prefix":"10.1016","volume":"30","author":[{"given":"James L.","family":"Abelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Uhde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2004.02.007_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archpsyc.1996.01830040059010","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol","volume":"53","author":"Abelson","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1176\/ajp.153.1.69","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis activity in panic disorder: prediction of long-term outcome by pre-treatment cortisol levels","volume":"153","author":"Abelson","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0006-3223(92)90138-P","article-title":"Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder","volume":"32","author":"Abelson","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-3956(95)00035-6","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis activity in panic disorder: effects of alprazolam on 24-hour secretion of adrenocorticotropin and cortisol","volume":"30","author":"Abelson","year":"1996","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-3223(89)90039-5","article-title":"Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers","volume":"26","author":"Amsterdam","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1176\/ajp.151.11.1626","article-title":"Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects","volume":"151","author":"Anand","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment","volume":"45","author":"Ballenger","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4530(94)E0021-Z","article-title":"Alpha2-adrenergic receptor sensitivity in panic disorder. I. GH response to GHRH and clonidine stimulation in panic disorder","volume":"20","author":"Brambilla","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.1986.01800110028005","article-title":"Abnormal regulation of noradrenergic function in panic disorder","volume":"43","author":"Charney","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1192\/bjp.170.2.159","article-title":"Enhanced growth hormone responses to pyridostigmine challenge in patients with panic disorder","volume":"170","author":"Cooney","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0006-3223(97)00056-5","article-title":"Specificity of the pyridostigmine\/growth hormone challenge in the diagnosis of depression","volume":"42","author":"Cooney","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/ajp.152.4.619","article-title":"Persistence of blunted growth hormone response to clonidine in fluoxetine-treated patients with panic disorder","volume":"152","author":"Coplan","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib13","first-page":"193","article-title":"A view on noradrenergic, hypothalamic\u2013pituitary\u2013adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine","volume":"33","author":"Coplan","year":"1997","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-1781(00)00173-6","article-title":"Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations","volume":"95","author":"Coplan","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0006-3223(00)00226-2","article-title":"Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined: integration of adult clinical follow-up data","volume":"47","author":"Coplan","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0006-3223(00)00932-X","article-title":"Low growth hormone response to growth hormone-releasing hormone in child depression","volume":"48","author":"Dahl","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/1043-2760(92)90168-Z","article-title":"Neuroendocrine control of growth hormone secretion in humans","volume":"3","author":"Devesa","year":"1992","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0006-3223(95)00068-2","article-title":"Growth hormone secretion timing in depression: clinical outcome comparisons","volume":"38","author":"Franz","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(94)90001-9","article-title":"Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dose","volume":"54","author":"Germine","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4530(99)00008-6","article-title":"Association of depressiveness with blunted growth hormone response to maximal physical exercise in young healthy men","volume":"24","author":"Harro","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000124986","article-title":"Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep-EEG in man","volume":"48","author":"Holsboer","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archpsyc.1990.01810140013002","article-title":"Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion","volume":"47","author":"Jarrett","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib23","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2003-030246","article-title":"Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men","volume":"88","author":"Jessup","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/jcem-40-3-501","article-title":"Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression","volume":"40","author":"Maeda","year":"1974","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jcem-60-3-505","article-title":"Diurnal hypersecretion of growth hormone in depression","volume":"60","author":"Mendlewicz","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.1989.01810020067011","article-title":"Altered central alpha2-adrenoreceptor sensitivity in panic disorder","volume":"46","author":"Nutt","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02191872","article-title":"Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls","volume":"245","author":"Pichot","year":"1995","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1176\/ajp.146.1.92","article-title":"Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder","volume":"146","author":"Rapaport","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-3223(91)90072-T","article-title":"Neuroendocrine effects of diazepam in panic and generalized anxiety disorders","volume":"30","author":"Roy-Byrne","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0278-5846(98)00018-9","article-title":"Growth hormone secretion during sleep in male depressed patients","volume":"22","author":"Sakkas","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0165-1781(88)90004-2","article-title":"Growth hormone response to clonidine in panic disorder patients","volume":"23","author":"Schittecatte","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib33","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1192\/bjp.154.6.858","article-title":"Tricyclic wash-out and growth hormone response to clonidine","volume":"154","author":"Schittecatte","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib34","first-page":"131","article-title":"New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine","volume":"19","author":"Siever","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-1781(82)90005-1","article-title":"Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls","volume":"6","author":"Siever","year":"1982","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2004.02.007_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0006-3223(94)90607-6","article-title":"A review of GHRH stimulation test in psychiatry","volume":"36","author":"Skare","year":"1994","journal-title":"Biol. Psychiatry"},{"year":"1986","series-title":"Structured Clinical Interview for DSM-III-R-Upjohn Version-Revised","author":"Spitzer","key":"10.1016\/j.psyneuen.2004.02.007_bib37"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1176\/ajp.150.2.336","article-title":"Blunted growth hormone responses to growth hormone releasing factor and to clonidine in panic disorder","volume":"150","author":"Tancer","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib39","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0006-3223(90)90420-7","article-title":"Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic disorder","volume":"27","author":"Tancer","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0006-3223(86)90291-X","article-title":"Blunted growth hormone response to clonidine in panic disorder patients","volume":"21","author":"Uhde","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib41","first-page":"101","article-title":"Evidence for hypothalamic-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers","volume":"6","author":"Uhde","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002130000491","article-title":"Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone","volume":"152","author":"Watson","year":"2000","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.psyneuen.2004.02.007_bib43","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000125937","article-title":"Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion","volume":"54","author":"Wiedemann","year":"1991","journal-title":"Neuroendocrinology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453004000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453004000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:25:27Z","timestamp":1759681527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453004000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306453004000940"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2004.02.007","relation":{},"ISSN":["0306-4530"],"issn-type":[{"type":"print","value":"0306-4530"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twenty-four hour growth hormone secretion in patients with panic disorder","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2004.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}